Why the study?
Do macrophages from patients with growth hormone deficiency exhibit increased lipoprotein lipase expression and foam cell formation compared to healthy controls?
Do macrophages from patients with growth hormone deficiency exhibit increased lipoprotein lipase expression and foam cell formation compared to healthy controls?
Macrophages from patients with growth hormone deficiency exhibit proatherogenic alterations, including increased lipoprotein lipase secretion and enhanced foam cell formation, providing a potential mechanism for their increased cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Supports macrophage-mediated atherogenesis in GH deficiency; hypothesis-generating and requires prospective validation before clinical translation.
GH deficiency is associated with increased prevalence of atherosclerosis, and recent data indicate a proatherogenic role for macrophage lipoprotein lipase (LPL) in the arterial wall. In this pilot study, we determined LPL expression and foam cell formation in monocyte-derived macrophages of 12 control subjects and nine patients with GH deficiency without GH replacement therapy. LPL mRNA levels, mass, and activity were increased in macrophages of patients with GH deficiency. In these subjects, macrophage LPL activity correlated with body mass index and fat mass. Incubation of patient macrophages with IGF-I for 24 h or differentiation of monocytes isolated from GH-deficient patients into macrophages in the presence of this growth factor decreased the amount of LPL mass. Compared with control cells, macrophages derived from GH-deficient patients took up and stored increased amounts of proatherogenic lipoproteins and were more easily converted to foam cells. In the supernatants of these cells, increased levels of free fatty acids and TNFalpha were also documented. These results demonstrate that macrophages of patients with GH deficiency secrete increased amounts of proatherogenic cytokines and are more susceptible to foam cell formation. These alterations may contribute to the increased cardiovascular risk in patients with GH deficiency.
No takes yet. Share an insight, caveat, or question.
Serri et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: